0000950170-24-070703.txt : 20240607 0000950170-24-070703.hdr.sgml : 20240607 20240607163012 ACCESSION NUMBER: 0000950170-24-070703 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OH ANDREW M. CENTRAL INDEX KEY: 0001746614 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 241030004 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS STREET 2: 325 VASSAR ST., STE. 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 ownership.xml 4 X0508 4 2024-06-05 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001746614 OH ANDREW M. C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 true false false false false Common Stock 2024-06-05 4 A false 4000 0.00 A 16000 D Stock Option (right to buy) 5.30 2024-06-05 4 A false 6000 0.00 A 2034-06-04 Common Stock 6000 6000 D The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. /s/ Todd Rosenthal, as attorney-in-fact/s/ Todd Rosenthal, as attorney-in-fact 2024-06-07